Delivery Order SPE2DU25D9439-SPE2DU26FEEFV
Award Date 3/2/26
Potential Completion Date 3/3/26
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $9,659.15 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Defense Department medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract program with a $499.9 million ceiling authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a $17,866.52 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense healthcare operations. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499,999,999 ceiling and a December 31, 2036 ultimate completion date. DMS Pharmaceutical Group is a woman-owned small business...
- The Defense Logistics Agency issued a $12,301.75 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical and medical consumables supply. PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract vehicle supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler....
- The Defense Logistics Agency issued a $178,092.88 delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide, with a...
- The Defense Logistics Agency issued a $1,737.68 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 17, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency program that authorizes firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and...
- The Defense Logistics Agency issued a $10,844.40 delivery order to DMS Pharmaceutical Group Inc. on February 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting recurring pharmaceutical supply needs of military healthcare facilities...
- The Defense Logistics Agency issued a $21,437.13 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical fleet supply. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036,...
- The Defense Logistics Agency issued a $1,525.41 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 22, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics,...
- The Defense Logistics Agency issued a $12,720.92 delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to...
- The Defense Logistics Agency issued a $17,896.70 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Defense Department medical supply requirements. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract vehicle with a $499.9 million ceiling, awarded to DMS Pharmaceutical Group on November 13, 2025, authorizing firm fixed-price delivery orders for...